Mass screening of hepatitis B and C in Burkina Faso: seroprevalence update and impact of hepatitis B vaccine
The prevalence of HBV and HCV infections remains high in Burkina Faso. Prevention strategies, including initial mass screening with rapid diagnostic tests and vaccination, need to be intensified.
Authors
- Dramane Kania (ORCID: https://orcid.org/0000-0003-1094-5449)
- Armel Moumouni Sanou (ORCID: https://orcid.org/0000-0002-4969-482X)
- Abou Coulibaly (ORCID: https://orcid.org/0000-0001-6015-3824)
- Ina Marie Angèle Traore (ORCID: https://orcid.org/0000-0003-0444-8972)
- Dieudonné Ilboudo (ORCID: https://orcid.org/0009-0008-7004-1461)
- A. Ouattara (ORCID: https://orcid.org/0009-0007-0773-3484)
- Sylvie Zida (ORCID: https://orcid.org/0000-0003-1727-2291)
- D Konaté
- Achille Sindimbasba Nikièma (ORCID: https://orcid.org/0000-0001-5041-4314)
- Abdoul Kader Ilboudo (ORCID: https://orcid.org/0000-0001-7241-5182)
- Delphine Napon‐Zongo (ORCID: https://orcid.org/0000-0002-1450-2189)
- Abdou Azaque Zouré (ORCID: https://orcid.org/0000-0002-9423-024X)
- Mathuola Nina Genéviève Ouattara (ORCID: https://orcid.org/0009-0003-0029-8847)
- Abdoulaye Dera (ORCID: https://orcid.org/0009-0001-3424-026X)
- Eric KYELEM
- D Lankoandé
Institutions
- Nazi Boni University (BF)
- Centre Muraz (BF)
- Institut de Recherche en Sciences de la Santé (BF)
Publication Details
- Journal
- The Journal of Infection in Developing Countries
- Published
- 2024-09-30
- DOI
- https://doi.org/10.3855/jidc.19673
- Citations
- 2
- Primary Topic
- Hepatitis B Virus Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.77